a) Stock-based compensation expense impact of SFAS No. 123R. We recognize
equity plan-related compensation expenses, which represent the fair
value of all share-based payments to employees, including grants of
employee stock options, as required under SFAS No. 123 (revised 2004),
"Share-Based Payment" (SFAS No. 123R).
b) Income tax benefit from tax valuation allowance release. This refers to
the recognition of an income tax benefit from the partial reversal of
our tax valuation allowance on specific deferred tax assets that is no
longer required. Under Statement of Financial Accounting Standards No.
109, the release of the tax valuation allowance is necessary, primarily
as a result of achieving sustained profitability in certain tax
jurisdictions.
Management adjusts for the excluded items because management believes that, in general, these items possess one or more of the following characteristics: their magnitude and timing is largely outside of Omnicell's control; they are unrelated to the ongoing operation of the business in the ordinary course; they are unusual and we do not expect them to occur in the ordinary course of business; or they are non-operational, or non-cash expenses involving stock option grants.
We believe that the presentation of these non-GAAP financial measures
is warranted for several reasons:
1) Such non-GAAP financial measures provide an additional analytical tool
for understanding Omnicell's financial performance by excluding the
impact of items which may obscure trends in the core operating results
of the
'/>"/>
| SOURCE Omnicell, Inc. Copyright©2008 PR Newswire. All rights reserved |